R. Alfonso

Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior

Javier Sastre, C. Fernández Pérez, T. Caldés, 2012, BMC Cancer.

Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer

E. Díaz-Rubio, J. Sastre, J. Puente, 2011, Anti-cancer drugs.

A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumours

L. Paz-Ares, A. Carcas, J. Frías, 2005, Cancer Chemotherapy and Pharmacology.

5-Fluorouracil as a protracted continuous infusion plus irinotecan (CPT-11) in patients with advanced colorectal cancer treated with fluoropyrimidine-based regimens as first line

E. Díaz-Rubio, J. Sastre, R. Alfonso, 2003, Anti-cancer drugs.

Combination therapy with gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, gemcitabine and cisplatin in patients with advanced solid tumors.

G. Peters, G. Giaccone, E. Smit, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Circulating tumor cells in solid tumor in metastatic and localized stages.

J. García-Saenz, Miguel Martín, E. Díaz-Rubio, 2009, Anticancer research.

Colon cancer molecular subtypes identified by expression profiling and associatedto stroma, mucinous type and different clinical behavior

C. Fernández Pérez, T. Caldés, A. Calles, 2012, BMC Cancer.

Risk-Adapted Adjuvant Chemotherapy After Concomitant Fluoropyrimidine-Radiotherapy Neoadjuvant Treatment for Patients With Resectable CT3-4 or N+ Rectal Cancer: Five-Year Disease-Free Survival Results of a Single-Center Series.

C. Fernández, E. Díaz-Rubio, J. Sastre, 2016, Clinical colorectal cancer.

Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables.

M. Sanz-Casla, J. García-Saenz, E. Díaz-Rubio, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Paclitaxel plus vinorelbine: an active regimen in metastatic breast cancer patients with prior anthracycline exposure.

J. Garcia-conde, A. Lluch, E. Díaz-Rubio, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.